Ana Filipa Raimundo

Ana Filipa Raimundo

Auto-generated profile, based on publicly available information

Ana Filipa Raimundo

BET - Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2020 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
ARAna F. Raimundo
Ana F. Raimundo
FFFilipa Félix
Filipa Félix
RARita Andrade
Rita Andrade
MGMaría-Teresa García-Conesa
María-Teresa García-Conesa
AGAntonio González-Sarrías
Antonio González-Sarrías
Regina MenezesRegina Menezes
Regina Menezes

1 January 2021 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
Regina MenezesRegina Menezes
Regina Menezes
Ivo MartinsIvo Martins
Ivo Martins
SFSofia Ferreira
Sofia Ferreira
ARAna F Raimundo
Ana F Raimundo
Alzheimer’s disease (AD) is a neurodegenerative disorder that affects millions worldwide. Due to population ageing, the incidence of AD is increasing. AD patients develop cognitive decline and dementia, features for which is known, requiring permanent care. This poses a major socio-economic burden on healthcare systems as AD patients’ relatives and healthcare workers are forced to cope with rising numbers of affected people. Despite recent advances, AD pathological mechanisms are not fully understood. Nevertheless, it is clear that the amyloid beta (Aβ) peptide, which forms amyloid plaques in AD patients’ brains, plays a key role. Type 2 diabetes, the most common form of diabetes, affects hundreds of million people globally. Islet amyloid polypeptide (IAPP) is a hormone co-produced and secreted with insulin in pancreatic β-cells, with a key role in diabetes, as it helps regulate glucose levels and control adiposity and satiation. Similarly to Aβ, IAPP is very amyloidogenic, generating intracellular amyloid deposits that cause β-cell dysfunction and death. It is now clear that IAPP can also have a pathological role in AD, decreasing cognitive function. IAPP harms the blood-brain barrier, directly interacts and co-deposits with Aβ, promoting diabetes-associated dementia. IAPP can cause a metabolic dysfunction in the brain, leading to other diabetes-related forms of AD. Thus, here we discuss IAPP association with diabetes, Aβ and dementia, in the context of what we designate a “diabetes brain phenotype” AD hypothesis. Such approach helps to set a conceptual framework for future IAPP-based drugs against AD.

21 August 2025 in bioRxiv
Verified
Preprint
Open access
Rafael CarechoRafael Carecho
Rafael Carecho
ARAna Filipa Raimundo
Ana Filipa Raimundo
María Ángeles Ávila-GálvezMaría Ángeles Ávila-Gálvez
María Ángeles Ávila-Gálvez
HLHugo Tainha Lopes
Hugo Tainha Lopes
CSCatarina de Oliveira Sequeira
Catarina de Oliveira Sequeira
CSCláudia Nunes dos Santos
Cláudia Nunes dos Santos
The growing burden of chronic neurodegenerative diseases (NDs), particularly Parkinson’s disease (PD), prompts the need for effective preventive strategies and treatments. Dietary (poly)phenols have emerged for their neuroprotective potential. This study investigated a (poly)phenol-enriched diet, comprising a berry mixture, to counteract key PD hallmarks in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated mice and elucidate the phenolic metabolic fingerprint underlying these effects. The berry-enriched diet prevented motor deficits in the MPTP mice model, preserved dopaminergic neurons in the midbrain, reduced glial activation and gene expression of inflammatory cytokines. Notably, berries also attenuated macrophage infiltration observed in the substantia nigra 7 days post-MPTP. Metabolomic analysis revealed distinct phenolic signatures in plasma and brain tissue between standard- and berry-fed mice. Overall, this pioneering study provides compelling evidence that a (poly)phenol-enriched diet may play a protective role in neurodegenerative disorders, highlighting its potential for future strategies to prevent or slow PD progression.

18 November 2019 in Palimpsesto - Revista do Programa de Pós-Graduação em Letras da UERJ
Verified
Journal Article
Open access
ARAna Luísa Macedo Raimundo
Ana Luísa Macedo Raimundo
Este artigo analisa a possibilidade de uma leitura das personagens Tia Nastácia e Emília da série Sítio do Picapau Amarelo de Monteiro Lobato (1931). Neste estudo investigamos uma analogia entre essas personagens que possibilitam enxergar em sua relação uma situação de autor e obra, já que Nastácia é responsável pela confecção de Emília na narrativa. A partir deste olhar e das concepções da Análise do Discurso de Linha Francesa, discutimos, baseados nos conceitos de autor/obra trabalhados por Bakhtin/Volochínov (2013-2014) e Foucault (2002), como Nastácia se encontra, dentro das narrativas, na posição-autor na produção da boneca Emília. Trabalhamos com enunciados selecionados na dispersão da saga a fim de comprovar a analogia entre as duas. Com isso, procuramos contribuir para um novo olhar interpretativo sobre essas personagens e as narrativas infantis lobatianas.

31 December 2021 in Biomedical and Biopharmaceutical Research
Verified
Journal Article
Closed access
SFSofia Ferreira
Sofia Ferreira
RTRejane Giacomelli Tavares
Rejane Giacomelli Tavares
Nuno SaraivaNuno Saraiva
Nuno Saraiva
Regina MenezesRegina Menezes
Regina Menezes
ARAna F. Raimundo
Ana F. Raimundo
FRFlavio H. Reginatto
Flavio H. Reginatto
Despite the progresses in therapeutics, type 2 diabetes is still an epidemic with alarming numbers worldwide. New strategies for prevention and treatments are imperative. A venue of research with potential is the aggregation of Islet Amyloid PolyPeptide (IAPP), a contributor to pancreatic β-cell dysfunction. To address the impact of IAPP on calcium (Ca2+) signalling, we developed a dual reporter yeast model independently expressing preproIAPP-GFP (ppIAPP) and encoding the lacZ gene under the control of Crz1-recognition elements. In this reporter system, ppIAPP induced Crz1 hyperactivation, a yeast transcription factor activated by the Ca2+/calmodulin/calcineurin pathway, which was followed by the increase in β-galactosidase activity. Encouraged by the reported healthy effects of Urticaceae plants against metabolic disturbances, we tested the protective potential of Cecropia pachystachya against IAPP-induced cytotoxicity using the newly designed yeast model. Although C. pachystachya extract exerted no beneficial effects towards the prevention of ppIAPP cytotoxicity, treatment with C. pachystachya enriched C-glycosyl flavonoid fraction (EFF-Cp) significantly improved viability of ppIAPP-expressing cells. Potential bioactivities of C. pachystachya extract and EFF-Cp towards the restoration of Ca2+ homeostasis disrupted by ppIAPP expression were also assessed. Neither prevented Crz1 hyperactivation, suggesting that the EFF-Cp-induced protection against ppIAPP toxicity was mediated by Ca2+-independent mechanisms. Keywords: Amylin, Calcium signaling; Cecropia pachystachya; Diabetes; Islet Amyloid Polypeptide (IAPP)

1 January 2022 in Biomedical and Biopharmaceutical Research
Verified
Journal Article
Closed access
SFSofia Ferreira
Sofia Ferreira
ARAna F. Raimundo
Ana F. Raimundo
IFInês Farrim
Inês Farrim
Regina MenezesRegina Menezes
Regina Menezes
Pancreatic deposition of Islet Amyloid PolyPeptide (IAPP) is a histopathological hallmark of type 2 diabetes. Inadequate processing of immature IAPP by proprotein convertases (PCs) leads to the accumulation of unprocessed forms, which in turn favors increased aggregate formation in pancreatic β-cells. Kexin 2 (Kex2) of Saccharomyces cerevisiae is the prototype of eukaryotic PCs family, but to date no direct correlations between Kex2 activity and preproIAPP processing in yeast have been reported. In this study we aimed to address the possible role of Kex2 on IAPP maturation as a tool to investigate the contribution of impaired processing towards IAPP proteototoxicity. Genetically modified S. cerevisiae models lacking the KEX2 gene and carrying different chimeric fusions of human IAPP linked to GFP were used. The cytotoxic effects of Kex2 ablation were assessed by means of growth curve analysis and cell viability assays using flow cytometry. IAPP protein profile was evaluated by immunoblotting assays using an anti-IAPP antibody. Intracellular IAPP aggregates were monitored by confocal fluorescence microscopy. Data showed that kex2 mutants exhibit growth defects, potentiated by preproIAPP-GFP, proIAPP-GFP and mature IAPP-GFP expression with an increased cytotoxicity for proIAPP-GFP. Notwithstanding, Kex2 absence does not seem to affect IAPP protein pattern nor the frequency/distribution of intracellular IAPP aggregates in yeast. Our findings suggest that Kex2 is not essential for IAPP processing in yeast, at least under the conditions tested. Keywords: Amylin, Islet Amyloid Polypeptide (IAPP), Kexin 2, Prohormone processing, Saccharomyces cerevisiae